## ILMN: Illumina, Inc. - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.62 indicates fundamental undervaluation. Quality metrics strong (ROE 31%). Consistent execution (3/4 quarters beat estimates). Caution: declining volume (39% of avg), momentum weakening (-1.9% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($127.05)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Pacer Advisors Inc. Acquires New Position in Illumina, Inc. $ILMN**
- Source: MarketBeat | 20251227T110855 | Somewhat-Bullish | Relevance: 100%
- Pacer Advisors Inc. has acquired a new position in Illumina, Inc. (NASDAQ:ILMN), purchasing 649,290 shares valued at approximately $61.66 million in the third quarter. This represents about 0.42% ownership of the life sciences company. Illumina recently surpassed quarterly earnings expectations with $1.34 EPS and $1.08 billion in revenue, and has set its FY2025 guidance at 4.650-4.750 EPS.

**2. Voya Investment Management LLC Has $5.23 Million Stock Holdings in Illumina, Inc. $ILMN**
- Source: MarketBeat | 20251226T130911 | Somewhat-Bullish | Relevance: 100%
- Voya Investment Management LLC decreased its stake in Illumina, Inc. by 32.8% in Q3, holding 55,027 shares valued at $5.23 million. Illumina surpassed Q3 earnings estimates with $1.34 EPS and $1.08 billion in revenue, prompting analysts to raise price targets, though the consensus remains a "Hold" with an average target of $118.31. Institutional investors collectively own approximately 89.4% of the company's stock.

**3. Swedbank AB Grows Position in Illumina, Inc. $ILMN**
- Source: MarketBeat | 20251225T111000 | Somewhat-Bullish | Relevance: 100%
- Swedbank AB significantly increased its stake in Illumina, Inc. (NASDAQ:ILMN) during the third quarter, raising its total holdings to 825,491 shares valued at approximately $78.4 million. This move comes as institutional investors now own 89.42% of the stock, alongside notable insider transactions including a director's purchase and another insider's sale. Illumina generally beat Q3 earnings expectations and carries a consensus "Hold" rating from analysts.

**4. Insiders Are Selling Illumina, Inc. (NASDAQ:ILMN) Stock**
- Source: MarketBeat | 20251224T050900 | Somewhat-Bullish | Relevance: 100%
- Assenagon Asset Management S.A. significantly reduced its holdings in Illumina, Inc. (NASDAQ:ILMN) by 91.7% in the third quarter. Despite this, Illumina reported strong Q3 earnings, beating expectations, and provided optimistic FY2025 guidance. The stock is currently trading up, with institutional investors owning a substantial portion of shares, though analyst ratings are mixed with a "Hold" consensus.

**5. Is Illumina Inc Gaining or Losing Market Support?**
- Source: Sahm | 20251224T041000 | Somewhat-Bearish | Relevance: 100%
- Illumina Inc (NYSE: ILMN) has seen a 7.9% increase in its short interest as a percentage of float, now standing at 6.83% of all available shares for trading. This increase signals a potentially more bearish market sentiment towards the stock by some investors. Despite this, Illumina's short interest is still lower than the peer group average of 7.44%.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Canaccord Genui | $130 | $112 | +16% |
| 2025-12-15 | Barclays | $110 | $100 | +10% |
| 2025-12-15 | JP Morgan | $130 | $105 | +24% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Canaccord Genui | main | Hold |
| 2025-12-15 | Barclays | main | Underweight |
| 2025-12-15 | JP Morgan | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.09M) |
| Sells | 11 ($80.42M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Capital World Invest: 13.1% (+20.0%)
- Blackrock Inc.: 12.2% (-3.5%)
- Vanguard Group Inc: 9.6% (-3.5%)
- State Street Corpora: 3.9% (+6.8%)
- Sessa Capital IM, L.: 3.1% (-0.8%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-1.9% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $80M sold (11 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +17%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.62 indicates undervaluation relative to growth. Forward P/E 26.9x stretched relative to 6% growth. Quality metrics strong (ROE 31%, margin 16%). Analyst sentiment positive (3 raises, avg +17%). Insider selling cluster ($80.4M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.7B |
| Beta | 1.44 |
| 52W Range | $68.70 - $153.06 |
| Short Interest | 7.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.62 |
| Forward P/E | 26.9 |
| Current P/E | 28.6 |
| YoY Growth | 6.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.0% to 1.1% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.9pp (needs >4.0% for momentum thesis). MRS_5 (-1.0%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). Volume at 39% of 20MA suggests lack of conviction. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.15% (CS: 68) | Neutral |
| RSI_14 | 61.1 | Neutral |
| MACD Histogram | -0.43 | Bearish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 1.116x | Above |
| vs SMA200 | 1.378x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $134.95
- **Stop Loss:** $127.05 (5.9% risk)
- **Target:** $150.75 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 167
- **Position Value:** $22,536.65
- **Portfolio %:** 22.54%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-05 (Est: $1.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.17 | $1.34 | +14.7% |
| 2025Q2 | $1.01 | $1.19 | +17.7% |
| 2025Q1 | $0.94 | $0.97 | +3.3% |
| 2024Q4 | $0.92 | $0.86 | -6.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*